Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association
Objectives: On the basis of survey results of the Acoustic Neuroma Association (ANA), we report patient ratings of postoperative headache (POH) symptoms, determine its effect on quality of life (QOL), and review the literature regarding POH after acoustic neuroma (AN) treatment. Study Design: In thi...
Gespeichert in:
| Veröffentlicht in: | The Laryngoscope 2005-04, Vol.115 (4), p.703-711 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 711 |
|---|---|
| container_issue | 4 |
| container_start_page | 703 |
| container_title | The Laryngoscope |
| container_volume | 115 |
| creator | Ryzenman, John Martin Pensak, Myles L. Tew Jr, John M. |
| description | Objectives: On the basis of survey results of the Acoustic Neuroma Association (ANA), we report patient ratings of postoperative headache (POH) symptoms, determine its effect on quality of life (QOL), and review the literature regarding POH after acoustic neuroma (AN) treatment.
Study Design: In this cohort study, 1,657 patients who underwent surgical treatment of AN reported their experiences of POH.
Methods: A detailed questionnaire was mailed to members of the ANA to identify preoperative and postoperative headache symptoms, complications, and long‐term effects on physical and psychosocial function. Questions were answered by 1657 (85.4%) respondents that were intended to qualify and quantify the effects of POH, including QOL issues. Responses were analyzed by tumor size, surgical approach, and patient age and sex. Statistical analysis was performed with the SPSS software.
Results: Preoperative headache was reported in approximately one third of respondents. Typical POHs occurred more than once daily (46%), lasted 1 to 4 hours in duration (43.1%), and were of moderate intensity (62.6%). The worst headaches were rated as “severe” by 77% of respondents. Treatment most often reported for typical headaches were nonprescription medications including nonsteroidal anti‐inflammatory drugs in 61.3% (P < .01) and regular use of narcotics in 15%. Patients who underwent the retrosigmoid approach were significantly more likely to report their worst POH as “severe” (82.3%) compared with the translabyrinthine (75.2%) and middle fossa approaches (63.3%). Women and younger patients tended to have poorer outcomes with regard to POHs.
Conclusions: In this large cohort study of AN patients, POH was a significant morbidity among AN patients with persistent headaches. Treating physicians should be aware of the risk factors identified and the effect POH has on the QOL when counseling patients regarding optimal treatment management. |
| doi_str_mv | 10.1097/01.mlg.0000161331.83224.c5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67702626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67702626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4847-1e4105b13b1ed38c3f2450ff9d6146c4f441c160e9f58e0f79a394910af317b03</originalsourceid><addsrcrecordid>eNqVkc9u1DAQhyNERZfCKyCLA6cm9cR2_vQWrdgWaVVooQJOltcZ7xqSuLUTQR6E98VlV_TACV9Gsr_5xqNfkrwGmgGtyzMKWd9tMxoPFMAYZBXLc55p8SRZgGCQ8roWT5MFpTlLK5F_OU6eh_At4iUT9FlyDKKioqrEIvl1iapVeofnpCHXk-rsOBNnyNoaJM2gujnYQOxAFFm6nfPjwyOcFqIkH9RocRgDuR1a9Ftnhy1ptJvCaDW5wsm7XpGPk9-in0_JDYapi7CJ12Tc4b9oE4LTNkrd8CI5MqoL-PJQT5Lb1dtPy8t0_f7i3bJZp5pXvEwBOVCxAbYBbFmlmcm5oMbUbQG80NxwDhoKirURFVJT1orVvAaqDINyQ9lJ8mbvvfPufsIwyt4GjV2nBoy_k0VZ0rzIiwie70HtXQgejbzztld-lkDlQyiSgoyhyMdQ5J9QpBax-dVhyrTpsX1sPaQQgdUe-GE7nP9DLdfNzVchOICgPC-jKN2LbBjx51-R8t_jKqwU8vPVheSrGpgoriVnvwG0tqxS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67702626</pqid></control><display><type>article</type><title>Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Ryzenman, John Martin ; Pensak, Myles L. ; Tew Jr, John M.</creator><creatorcontrib>Ryzenman, John Martin ; Pensak, Myles L. ; Tew Jr, John M.</creatorcontrib><description>Objectives: On the basis of survey results of the Acoustic Neuroma Association (ANA), we report patient ratings of postoperative headache (POH) symptoms, determine its effect on quality of life (QOL), and review the literature regarding POH after acoustic neuroma (AN) treatment.
Study Design: In this cohort study, 1,657 patients who underwent surgical treatment of AN reported their experiences of POH.
Methods: A detailed questionnaire was mailed to members of the ANA to identify preoperative and postoperative headache symptoms, complications, and long‐term effects on physical and psychosocial function. Questions were answered by 1657 (85.4%) respondents that were intended to qualify and quantify the effects of POH, including QOL issues. Responses were analyzed by tumor size, surgical approach, and patient age and sex. Statistical analysis was performed with the SPSS software.
Results: Preoperative headache was reported in approximately one third of respondents. Typical POHs occurred more than once daily (46%), lasted 1 to 4 hours in duration (43.1%), and were of moderate intensity (62.6%). The worst headaches were rated as “severe” by 77% of respondents. Treatment most often reported for typical headaches were nonprescription medications including nonsteroidal anti‐inflammatory drugs in 61.3% (P < .01) and regular use of narcotics in 15%. Patients who underwent the retrosigmoid approach were significantly more likely to report their worst POH as “severe” (82.3%) compared with the translabyrinthine (75.2%) and middle fossa approaches (63.3%). Women and younger patients tended to have poorer outcomes with regard to POHs.
Conclusions: In this large cohort study of AN patients, POH was a significant morbidity among AN patients with persistent headaches. Treating physicians should be aware of the risk factors identified and the effect POH has on the QOL when counseling patients regarding optimal treatment management.</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1097/01.mlg.0000161331.83224.c5</identifier><identifier>PMID: 15805885</identifier><language>eng</language><publisher>Hoboken, NJ: John Wiley & Sons, Inc</publisher><subject>Acoustic neuroma ; Acoustic Neuroma Association ; Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Analgesics, Opioid - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Cohort Studies ; Cranial Fossa, Middle - surgery ; Cranial Sinuses - surgery ; Ear, Inner - surgery ; Female ; Headache - drug therapy ; Headache - psychology ; Health Status ; Humans ; Male ; Middle Aged ; Neuroma, Acoustic - classification ; Neuroma, Acoustic - surgery ; Nonprescription Drugs - therapeutic use ; Postoperative Complications - psychology ; postoperative headache ; preoperative headache ; Quality of Life ; Risk Factors ; Sex Factors ; Treatment Outcome</subject><ispartof>The Laryngoscope, 2005-04, Vol.115 (4), p.703-711</ispartof><rights>Copyright © 2005 The Triological Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4847-1e4105b13b1ed38c3f2450ff9d6146c4f441c160e9f58e0f79a394910af317b03</citedby><cites>FETCH-LOGICAL-c4847-1e4105b13b1ed38c3f2450ff9d6146c4f441c160e9f58e0f79a394910af317b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1097%2F01.mlg.0000161331.83224.c5$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1097%2F01.mlg.0000161331.83224.c5$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15805885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ryzenman, John Martin</creatorcontrib><creatorcontrib>Pensak, Myles L.</creatorcontrib><creatorcontrib>Tew Jr, John M.</creatorcontrib><title>Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association</title><title>The Laryngoscope</title><addtitle>The Laryngoscope</addtitle><description>Objectives: On the basis of survey results of the Acoustic Neuroma Association (ANA), we report patient ratings of postoperative headache (POH) symptoms, determine its effect on quality of life (QOL), and review the literature regarding POH after acoustic neuroma (AN) treatment.
Study Design: In this cohort study, 1,657 patients who underwent surgical treatment of AN reported their experiences of POH.
Methods: A detailed questionnaire was mailed to members of the ANA to identify preoperative and postoperative headache symptoms, complications, and long‐term effects on physical and psychosocial function. Questions were answered by 1657 (85.4%) respondents that were intended to qualify and quantify the effects of POH, including QOL issues. Responses were analyzed by tumor size, surgical approach, and patient age and sex. Statistical analysis was performed with the SPSS software.
Results: Preoperative headache was reported in approximately one third of respondents. Typical POHs occurred more than once daily (46%), lasted 1 to 4 hours in duration (43.1%), and were of moderate intensity (62.6%). The worst headaches were rated as “severe” by 77% of respondents. Treatment most often reported for typical headaches were nonprescription medications including nonsteroidal anti‐inflammatory drugs in 61.3% (P < .01) and regular use of narcotics in 15%. Patients who underwent the retrosigmoid approach were significantly more likely to report their worst POH as “severe” (82.3%) compared with the translabyrinthine (75.2%) and middle fossa approaches (63.3%). Women and younger patients tended to have poorer outcomes with regard to POHs.
Conclusions: In this large cohort study of AN patients, POH was a significant morbidity among AN patients with persistent headaches. Treating physicians should be aware of the risk factors identified and the effect POH has on the QOL when counseling patients regarding optimal treatment management.</description><subject>Acoustic neuroma</subject><subject>Acoustic Neuroma Association</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Cohort Studies</subject><subject>Cranial Fossa, Middle - surgery</subject><subject>Cranial Sinuses - surgery</subject><subject>Ear, Inner - surgery</subject><subject>Female</subject><subject>Headache - drug therapy</subject><subject>Headache - psychology</subject><subject>Health Status</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuroma, Acoustic - classification</subject><subject>Neuroma, Acoustic - surgery</subject><subject>Nonprescription Drugs - therapeutic use</subject><subject>Postoperative Complications - psychology</subject><subject>postoperative headache</subject><subject>preoperative headache</subject><subject>Quality of Life</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Treatment Outcome</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkc9u1DAQhyNERZfCKyCLA6cm9cR2_vQWrdgWaVVooQJOltcZ7xqSuLUTQR6E98VlV_TACV9Gsr_5xqNfkrwGmgGtyzMKWd9tMxoPFMAYZBXLc55p8SRZgGCQ8roWT5MFpTlLK5F_OU6eh_At4iUT9FlyDKKioqrEIvl1iapVeofnpCHXk-rsOBNnyNoaJM2gujnYQOxAFFm6nfPjwyOcFqIkH9RocRgDuR1a9Ftnhy1ptJvCaDW5wsm7XpGPk9-in0_JDYapi7CJ12Tc4b9oE4LTNkrd8CI5MqoL-PJQT5Lb1dtPy8t0_f7i3bJZp5pXvEwBOVCxAbYBbFmlmcm5oMbUbQG80NxwDhoKirURFVJT1orVvAaqDINyQ9lJ8mbvvfPufsIwyt4GjV2nBoy_k0VZ0rzIiwie70HtXQgejbzztld-lkDlQyiSgoyhyMdQ5J9QpBax-dVhyrTpsX1sPaQQgdUe-GE7nP9DLdfNzVchOICgPC-jKN2LbBjx51-R8t_jKqwU8vPVheSrGpgoriVnvwG0tqxS</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Ryzenman, John Martin</creator><creator>Pensak, Myles L.</creator><creator>Tew Jr, John M.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200504</creationdate><title>Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association</title><author>Ryzenman, John Martin ; Pensak, Myles L. ; Tew Jr, John M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4847-1e4105b13b1ed38c3f2450ff9d6146c4f441c160e9f58e0f79a394910af317b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acoustic neuroma</topic><topic>Acoustic Neuroma Association</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Cohort Studies</topic><topic>Cranial Fossa, Middle - surgery</topic><topic>Cranial Sinuses - surgery</topic><topic>Ear, Inner - surgery</topic><topic>Female</topic><topic>Headache - drug therapy</topic><topic>Headache - psychology</topic><topic>Health Status</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuroma, Acoustic - classification</topic><topic>Neuroma, Acoustic - surgery</topic><topic>Nonprescription Drugs - therapeutic use</topic><topic>Postoperative Complications - psychology</topic><topic>postoperative headache</topic><topic>preoperative headache</topic><topic>Quality of Life</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ryzenman, John Martin</creatorcontrib><creatorcontrib>Pensak, Myles L.</creatorcontrib><creatorcontrib>Tew Jr, John M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ryzenman, John Martin</au><au>Pensak, Myles L.</au><au>Tew Jr, John M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association</atitle><jtitle>The Laryngoscope</jtitle><addtitle>The Laryngoscope</addtitle><date>2005-04</date><risdate>2005</risdate><volume>115</volume><issue>4</issue><spage>703</spage><epage>711</epage><pages>703-711</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><abstract>Objectives: On the basis of survey results of the Acoustic Neuroma Association (ANA), we report patient ratings of postoperative headache (POH) symptoms, determine its effect on quality of life (QOL), and review the literature regarding POH after acoustic neuroma (AN) treatment.
Study Design: In this cohort study, 1,657 patients who underwent surgical treatment of AN reported their experiences of POH.
Methods: A detailed questionnaire was mailed to members of the ANA to identify preoperative and postoperative headache symptoms, complications, and long‐term effects on physical and psychosocial function. Questions were answered by 1657 (85.4%) respondents that were intended to qualify and quantify the effects of POH, including QOL issues. Responses were analyzed by tumor size, surgical approach, and patient age and sex. Statistical analysis was performed with the SPSS software.
Results: Preoperative headache was reported in approximately one third of respondents. Typical POHs occurred more than once daily (46%), lasted 1 to 4 hours in duration (43.1%), and were of moderate intensity (62.6%). The worst headaches were rated as “severe” by 77% of respondents. Treatment most often reported for typical headaches were nonprescription medications including nonsteroidal anti‐inflammatory drugs in 61.3% (P < .01) and regular use of narcotics in 15%. Patients who underwent the retrosigmoid approach were significantly more likely to report their worst POH as “severe” (82.3%) compared with the translabyrinthine (75.2%) and middle fossa approaches (63.3%). Women and younger patients tended to have poorer outcomes with regard to POHs.
Conclusions: In this large cohort study of AN patients, POH was a significant morbidity among AN patients with persistent headaches. Treating physicians should be aware of the risk factors identified and the effect POH has on the QOL when counseling patients regarding optimal treatment management.</abstract><cop>Hoboken, NJ</cop><pub>John Wiley & Sons, Inc</pub><pmid>15805885</pmid><doi>10.1097/01.mlg.0000161331.83224.c5</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0023-852X |
| ispartof | The Laryngoscope, 2005-04, Vol.115 (4), p.703-711 |
| issn | 0023-852X 1531-4995 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67702626 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Acoustic neuroma Acoustic Neuroma Association Adolescent Adult Age Factors Aged Aged, 80 and over Analgesics, Opioid - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Cohort Studies Cranial Fossa, Middle - surgery Cranial Sinuses - surgery Ear, Inner - surgery Female Headache - drug therapy Headache - psychology Health Status Humans Male Middle Aged Neuroma, Acoustic - classification Neuroma, Acoustic - surgery Nonprescription Drugs - therapeutic use Postoperative Complications - psychology postoperative headache preoperative headache Quality of Life Risk Factors Sex Factors Treatment Outcome |
| title | Headache: A Quality of Life Analysis in a Cohort of 1,657 Patients Undergoing Acoustic Neuroma Surgery, Results from the Acoustic Neuroma Association |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A47%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Headache:%20A%20Quality%20of%20Life%20Analysis%20in%20a%20Cohort%20of%201,657%20Patients%20Undergoing%20Acoustic%20Neuroma%20Surgery,%20Results%20from%20the%20Acoustic%20Neuroma%20Association&rft.jtitle=The%20Laryngoscope&rft.au=Ryzenman,%20John%20Martin&rft.date=2005-04&rft.volume=115&rft.issue=4&rft.spage=703&rft.epage=711&rft.pages=703-711&rft.issn=0023-852X&rft.eissn=1531-4995&rft_id=info:doi/10.1097/01.mlg.0000161331.83224.c5&rft_dat=%3Cproquest_cross%3E67702626%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67702626&rft_id=info:pmid/15805885&rfr_iscdi=true |